These data indicated that two-dose hUCMSC treatment significantly upregulated IDO expression and increased the percentages of Treg infiltrates in the heart and circulation of DCM rats, which may alleviate systemic inflammation. This evidence concerns the gene IDO1 and familial dilated cardiomyopathy.